{
  "meta": {
    "title": "General_Considerations_About_Anti-Microbial_Agents",
    "url": "https://brainandscalpel.vercel.app/general-considerations-about-anti-microbial-agents-553a5fcf.html",
    "scrapedAt": "2025-11-29T18:33:35.638Z"
  },
  "questions": [
    {
      "id": 12760,
      "choices": [
        {
          "id": 51002,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Gentamicin</span></span></span></p>"
        },
        {
          "id": 51003,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ethionamide</span></span></span></p>"
        },
        {
          "id": 51004,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Vancomycin</span></span></span></p>"
        },
        {
          "id": 51005,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Acyclovir</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a 2<sup>nd</sup> line anti-TB drug?</span></span></span></p>",
      "unique_key": "Q1771984",
      "question_audio": null,
      "question_video": null,
      "map_id": 36355,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B. Ethionamide</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><strong>Ethionamide</strong> is a<strong> second-line antitubercular drug, </strong>primarily used when there is <strong>resistance to first-line treatments </strong>or when the patient<strong> cannot tolerate them</strong>. <strong>Ethionamide works similarly to isoniazid, inhibiting the synthesis of mycolic acid</strong>, an<strong> essential</strong> component of the <strong>bacterial cell wall in Mycobacterium tuberculosis.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Option A. Gentamicin</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">: This is an<strong> aminoglycoside</strong> and i<strong>s not used in tuberculosis. Streptomycin</strong> is used as<strong> second-line drug</strong> in <strong>tuberculosis.</strong></span></span></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Option C. Vancomycin</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">: This is<strong> not</strong> used in <strong>TB treatment</strong> at all; it is<strong> effective against Gram-positive bacteria, </strong>especially for <strong>serious</strong> <strong>infections like MRSA.</strong></span></span></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Option D. Acyclovir</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">: This<strong> drug is an antiviral</strong>, used for<strong> viral infections such as herpes simplex and varicella-zoster,</strong> not tuberculosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:black\">Antitubercular Drugs</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture29.jpg\" style=\"height:633px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 51003,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12693,
      "choices": [
        {
          "id": 50734,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thiamine</span></span></span></p>"
        },
        {
          "id": 50735,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Folic acid</span></span></span></p>"
        },
        {
          "id": 50736,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyridoxine</span></span></span></p>"
        },
        {
          "id": 50737,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin B12</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient on antitubercular drug therapy developed a tingling sensation on lower limb. Which of the following drugs should be used for the treatment?</span></span></span></p>",
      "unique_key": "Q3448067",
      "question_audio": null,
      "question_video": null,
      "map_id": 36340,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Pyridoxine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> tingling sensation</strong>, also known as <strong>paresthesia,</strong> is likely indicative of<strong> peripheral neuropathy. </strong>In the context of <strong>antitubercular</strong> <strong>therapy,</strong> especially with the<strong> use of isoniazid (INH),</strong> this is a recognized<strong> side effect.</strong> <strong>Isoniazid</strong> interferes with the <strong>metabolism of</strong> <strong>pyridoxine (vitamin B6),</strong> which can lead to <strong>its deficiency.</strong> This deficiency is often manifested as<strong> peripheral neuropathy</strong>, which includes symptoms like <strong>tingling or numbness in the extremities. Pyridoxine supplementation</strong> is commonly recommended to<strong> prevent</strong> and <strong>treat </strong>this condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Thiamine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While <strong>thiamine deficiency </strong>can also cause <strong>peripheral neuropathy,</strong> it is<strong> not</strong> typically associated with <strong>antitubercular drug therapy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Folic acid</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Folic acid</strong> is important for <strong>cell division and growth, </strong>and its deficiency can lead to<strong> anemia</strong>, but it is<strong> not</strong> typically used to treat <strong>drug-induced neuropathy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Vitamin B12</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Deficiency in vitamin B12</strong> can lead to <strong>neuropathy as well; </strong>however, the neuropathy associated with <strong>antitubercular drugs</strong>, specifically<strong> INH</strong>, is related to<strong> pyridoxine deficiency, </strong>not vitamin B12.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoniazid Induced Neurotoxicity </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Isoniazid </strong>interferes with the <strong>utilization of pyridoxine </strong>and <strong>increases its urinary excretion,</strong> causing <strong>pyridoxine deficiency,</strong> which manifests as<strong> peripheral neuritis</strong> and a variety of <strong>neurologic manifestations (paresthesia&rsquo;s, numbness, mental</strong> <strong>disturbances</strong>), accounting for the most important <strong>dose dependent toxic effects of INH.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyridoxine </strong>is used to <strong>prevent as well as treat </strong>the<strong> neurotoxicity</strong> caused by <strong>isoniazid. </strong></span></span><strong> </strong></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 50736,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12705,
      "choices": [
        {
          "id": 50782,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amphotericin B</span></span></span></p>"
        },
        {
          "id": 50783,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin</span></span></span></p>"
        },
        {
          "id": 50784,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doxycycline</span></span></span></p>"
        },
        {
          "id": 50785,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Gentamicin</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dose reduction is required in renal failure with all of the following antimicrobials except?</span></span></span></p>",
      "unique_key": "Q5744932",
      "question_audio": null,
      "question_video": null,
      "map_id": 36344,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Doxycycline</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Doxycycline</strong> is an <strong>exception</strong> when it comes to the need for <strong>dose adjustment in patients with renal failure</strong>.<strong> Unlike</strong> many other antibiotics, <strong>doxycycline is primarily excreted in the feces </strong>via <strong>biliary secretion</strong> and <strong>does not require dose adjustment in patients</strong> with <strong>impaired renal function</strong>. This makes it a<strong> safer choice </strong>in the treatment of<strong> infections in patients with renal complications.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Amphotericin B</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Although <strong>primarily eliminated via the liver,</strong> Amphotericin B can cause <strong>nephrotoxicity, </strong>and <strong>careful</strong> <strong>monitoring is recommended </strong>in patients with<strong> renal impairment</strong>. However, it generally <strong>does not</strong> require <strong>dose adjustments </strong>solely based on<strong> renal function </strong>but requires<strong> careful monitoring.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Vancomycin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Requires dose adjustment in renal failure </strong>due to its <strong>elimination primarily through the kidney</strong>s.<strong> Inadequate</strong> <strong>dosing </strong>adjustments can lead to<strong> toxicity, </strong>including<strong> nephrotoxicity and ototoxicity.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Gentamicin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Is <strong>nephrotoxic</strong> and requires<strong> significant dose adjustments </strong>in patients with <strong>renal failure.</strong> It is excreted almost entirely by the <strong>kidneys</strong>, and <strong>improper dosing</strong> can lead to <strong>increased toxicity.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibiotics Safe in Renal Failure</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture2.jpg\" style=\"height:501px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 50784,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12810,
      "choices": [
        {
          "id": 51202,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abacavir</span></span></span></p>"
        },
        {
          "id": 51203,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indinavir</span></span></span></p>"
        },
        {
          "id": 51204,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enfuvirtide</span></span></span></p>"
        },
        {
          "id": 51205,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oseltamivir</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following binds to viral envelope glycoprotein preventing the conformational changes required for the fusion of viral and cellular membranes?</span></span></span></p>",
      "unique_key": "Q2358513",
      "question_audio": null,
      "question_video": null,
      "map_id": 36335,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Enfuvirtide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Enfuvirtide,</strong> known as<strong> T-20,</strong> is an <strong>antiretroviral drug </strong>used in the management of <strong>HIV infection. </strong>It functions as a <strong>fusion inhibitor,</strong> meaning it<strong> blocks the HIV virus&#39;s ability to fuse</strong> with th<strong>e host cell membranes</strong>. It achieves this by <strong>binding to the viral envelope</strong> <strong>glycoprotein gp41.</strong> This prevents the necessary conformational changes<strong> gp41 </strong>must <strong>undergo for the virus </strong>to successfully<strong> fuse</strong> with and <strong>enter the host cell</strong>, thus<strong> halting the infection process</strong> at an<strong> early stage.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Abacavir:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect </strong>because Abacavir is a<strong> nucleoside analogue reverse transcriptase inhibitor (NRTI),</strong> <strong>not</strong> a<strong> fusion</strong> <strong>inhibitor.</strong> It works by becoming incorporated into the<strong> viral DNA and causing chain termination.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Indinavir:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect </strong>as Indinavir is a <strong>protease inhibito</strong>r used in the treatment of<strong> HIV.</strong> It <strong>prevents </strong>the cleavage of <strong>viral</strong> <strong>polypeptides</strong> into <strong>functional viral proteins.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Oseltamivir:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect</strong> because <strong>Oseltamivir</strong> is an <strong>antiviral medication</strong> used to <strong>treat and prevent influenza, </strong>not HIV. It works by<strong> inhibiting the neuraminidase enzyme </strong>on the<strong> surface </strong>of <strong>the influenza virus,</strong> which is necessary for the <strong>release of progeny</strong> <strong>virus from infected cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Enfuvirtide</strong> is a unique<strong> antiretroviral drug </strong>used to <strong>treat HIV infection</strong> that works as a<strong> fusion inhibitor, </strong>blocking the <strong>HIV virus&#39;s ability</strong> to <strong>enter and infect host cells</strong> by<strong> targeting the gp41 glycoprotein.</strong></span></span></span></span></span></span></span></p>",
      "correct_choice_id": 51204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12728,
      "choices": [
        {
          "id": 50874,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conjugation</span></span></span></p>"
        },
        {
          "id": 50875,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transduction</span></span></span></p>"
        },
        {
          "id": 50876,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transformation</span></span></span></p>"
        },
        {
          "id": 50877,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transposition</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The process shown in figure is an important method of transfer of drug resistance in bacteria. This mechanism of horizontal transfer of drug resistance is known as?</span></span></span>​​​</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture11.jpg\" style=\"height:340px; width:300px\" /></p>",
      "unique_key": "Q8613354",
      "question_audio": null,
      "question_video": null,
      "map_id": 36346,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Conjugation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Horizontal transfer of drug resistance </strong>in bacteria refers to the<strong> transfer of resistance genes</strong> between <strong>different bacterial species.</strong> This <strong>transfer </strong>can occur through <strong>several mechanisms</strong>, including:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Conjugation</strong> is the transfer of <strong>genetic material between bacteria</strong> by <strong>direct cell-to-cell contact</strong>. During conjugation, a <strong>plasmid (a</strong> <strong>small, circular piece of DNA)</strong> that contains a<strong> resistance gene</strong> can be<strong> transferred </strong>from <strong>one bacterium to another, </strong>allowing the <strong>recipient bacterium to become resistant to the drug.</strong> It is <strong>most common</strong> method of <strong>horizontal transfer of drug resistance.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Transduction:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is the transfer of <strong>genetic material between bacteria by a bacteriophage </strong>(a virus that<strong> infects bacteria</strong>). If the<strong> genetic material contains a resistance gene</strong>, the bacterium can incorporate it into <strong>its genome </strong>and become<strong> resistant to the drug.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Transformation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is the <strong>uptake of free DNA </strong>from the environment by a <strong>bacterial cell</strong>. If the <strong>DNA contains</strong> a <strong>resistance</strong> <strong>gene, the bacterium </strong>can incorporate it into<strong> its genome </strong>and become<strong> resistant to the drug</strong>. It is<strong> least common</strong> method of <strong>horizontal</strong> <strong>transfer of resistance.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Transposition:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is the<strong> movement of a DNA sequence (</strong>such as a <strong>resistance gene)</strong> from <strong>one location in the genome </strong>to <strong>another</strong>. Transposition occurs due to<strong> jumping genes </strong>called<strong> transposons.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Conjugation </strong>is a critical pathway for the <strong>horizontal transfer of genetic material,</strong> such as <strong>antibiotic resistance genes</strong>, <strong>between</strong> <strong>bacterial cells</strong>. This<strong> mode of genetic exchange </strong>plays a significant role in the <strong>spread of resistance in bacterial populations,</strong> <strong>highlighting the importance of understanding </strong>and <strong>monitoring antibiotic</strong> use to manage the <strong>risk of resistant infections.</strong></span></span></span></p>",
      "correct_choice_id": 50874,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12797,
      "choices": [
        {
          "id": 51150,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pharmaceutical compatibility.</span></span></span></p>"
        },
        {
          "id": 51151,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CYP3A4 inhibition by ritonavir.</span></span></span></p>"
        },
        {
          "id": 51152,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Long elimination half-life or ritonavir.</span></span></span></p>"
        },
        {
          "id": 51153,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ability to counteract side- effects of lopinavir.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the rationale of combining ritonavir with lopinavir?</span></span></span></p>",
      "unique_key": "Q7579110",
      "question_audio": null,
      "question_video": null,
      "map_id": 36365,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. CYP3A4 inhibition by ritonavir</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ritonavir </strong>is used in <strong>combination with lopinavir </strong>primarily due to its <strong>potent inhibitory effect on the cytochrome P450 3A4 (CYP3A4)</strong> enzyme. This enzyme is crucial in the <strong>metabolism of many drugs,</strong> including <strong>lopinavir.</strong> By <strong>inhibiting CYP3A4,</strong> <strong>ritonavir reduces </strong>the <strong>metabolic breakdown of lopinavir,</strong> thereby <strong>increasing its plasma concentration and enhancing its therapeutic efficacy.</strong> This strategic use of <strong>ritonavir to boost the pharmacokinetic profile </strong>of other <strong>protease inhibitors </strong>is known as <strong>&quot;pharmacokinetic</strong> <strong>enhancement&quot; or &quot;boosting.&quot;</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Pharmaceutical compatibility:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While<strong> ritonavir and lopinavir </strong>are compatible for combination in a<strong> single formulation,</strong> this is <strong>not </strong>the primary rationale for their use together.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Long elimination half-life of ritonavir:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Ritonavir</strong> <strong>does not</strong> have a particularly <strong>long half-life;</strong> rather, its role in the combination is to <strong>inhibit the metabolism of lopinavir.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ability to counteract side-effects of lopinavir:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The combination is<strong> not intended to counteract side effects</strong> but to <strong>enhance</strong> <strong>lopinavir&#39;s pharmacokinetic profile.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The primary reason for <strong>combining ritonavir with lopinavir in HIV treatment regimens </strong>is to<strong> utilize ritonavir&#39;s ability to inhibit CYP3A4,</strong> thereby <strong>increasing the effectiveness of lopinavir </strong>through<strong> higher and more sustained plasma concentrations. </strong>This is a key strategy in<strong> optimizing antiretroviral therapy,</strong> especially in treatment-<strong>experienced or resistant cases.</strong></span></span></span></p>",
      "correct_choice_id": 51151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12655,
      "choices": [
        {
          "id": 50582,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of M2 receptor</span></span></span></p>"
        },
        {
          "id": 50583,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuraminidase inhibition</span></span></span></p>"
        },
        {
          "id": 50584,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of RNA dependent DNA Polymerase</span></span></span></p>"
        },
        {
          "id": 50585,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apoptosis of infected cells</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism of action of Oseltamivir as an antiviral agent is?</span></span></span></p>",
      "unique_key": "Q8532871",
      "question_audio": null,
      "question_video": null,
      "map_id": 36358,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Neuraminidase inhibition</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oseltamivir</strong> functions as an <strong>antiviral agent </strong>primarily through the<strong> inhibition of the neuraminidase enzyme.</strong> This enzyme, found on the <strong>surface of influenza viruses</strong>, plays a crucial role in the<strong> viral life cycle by cleaving sialic acid residues. </strong>This <strong>cleavage is essential fo</strong>r the release of <strong>newly formed viral particles from infected host cells</strong> and their <strong>subsequent spread to uninfected cells</strong>. By <strong>blocking</strong> this process, <strong>oseltamivir effectively hampers the spread of the virus within the body, </strong>helping to <strong>decrease both the severity </strong>and <strong>duration of flu symptoms</strong>. It is crucial to note that for<strong> maximum effectiveness</strong>,<strong> oseltamivir </strong>should be <strong>administered within the first 48</strong> hours<strong> after symptoms appear. </strong>This treatment, however, <strong>does not </strong>replace the need for regular <strong>influenza vaccination.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Inhibition of M2 receptor</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is<strong> incorrect for oseltamivir.</strong> The<strong> M2 protein ion channel inhibition</strong> is a mechanism utilized by antiviral medications like <strong>amantadine and rimantadine</strong>, which are <strong>different from oseltamivir</strong> and <strong>target a distinct part of the</strong> <strong>influenza virus.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Inhibition of RNA dependent DNA Polymerase</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Incorrect</strong> for <strong>oseltamivir</strong>. <strong>RNA-dependent DNA polymerase,</strong> or <strong>reverse</strong> <strong>transcriptase</strong>, is targeted by<strong> antiretroviral drugs</strong> such as <strong>zidovudine and lamivudine</strong>, which are used <strong>against retroviruses like HIV,</strong> <strong>not influenza.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Apoptosis of infected cells</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This statement is <strong>incorrect</strong> as there are <strong>no antiviral medications</strong>, including<strong> oseltamivir, </strong>that act by <strong>inducing apoptosis directly in infected cells</strong>. Apoptosis is <strong>a natural defense mechanism</strong> used by the body to<strong> eliminate infected</strong> <strong>or damaged cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oseltamivir&#39;s</strong> mechanism of action involves the<strong> inhibition of neuraminidase</strong>, an enzyme crucial for the <strong>release and spread of</strong> <strong>influenza virus </strong>particles, making it an<strong> effective treatment</strong> for<strong> reducing flu symptoms</strong> when <strong>administered early.</strong></span></span><strong> </strong></span></span></span></span></p>",
      "correct_choice_id": 50583,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12787,
      "choices": [
        {
          "id": 51110,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">INH</span></span></span></p>"
        },
        {
          "id": 51111,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifampicin</span></span></span></p>"
        },
        {
          "id": 51112,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Streptomycin</span></span></span></p>"
        },
        {
          "id": 51113,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethambutol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old pregnant woman develops tuberculosis. Which of the following anti tubercular drugs should not be used? </span></span></span></p>",
      "unique_key": "Q6090082",
      "question_audio": null,
      "question_video": null,
      "map_id": 36359,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Streptomycin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Streptomycin</strong> is <strong>contraindicated in pregnant women </strong>because it belongs to the<strong> aminoglycoside class of antibiotics</strong>, which are known to be <strong>ototoxic</strong> (can cause damage to the ear). There is a <strong>risk</strong> that the drug could <strong>cause congenital deafness in the fetus.</strong> Therefore, <strong>streptomycin </strong>should be <strong>avoided during pregnancy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. INH (Isoniazid):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Generally considered<strong> safe for use during pregnancy </strong>and is a<strong> crucial component </strong>of <strong>antitubercular therapy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Rifampicin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Also considered<strong> safe in pregnancy a</strong>nd is a<strong> key drug</strong> in the<strong> treatment of tuberculosis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ethambutol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Usually <strong>safe during pregnancy </strong>and can be used as part of the <strong>antitubercular drug regimen.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Streptomycin</strong> is<strong> absolutely contraindicated</strong> in<strong> pregnant females.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyrazinamide </strong>should be<strong> avoided in pregnancy.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Isoniaid, rifampicin, and ethambutol</strong> are <strong>safe in pregnancy.</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 51112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12689,
      "choices": [
        {
          "id": 50718,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Cotrimoxazole</span></span></span></span></p>"
        },
        {
          "id": 50719,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Amoxicillin</span></span></span></span></p>"
        },
        {
          "id": 50720,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Dexamethasone</span></span></span></span></p>"
        },
        {
          "id": 50721,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Cephalosporin</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:16px\">A 55-year-old male patient undergoing chemotherapy for non-Hodgkin lymphoma is at an increased risk of infections due to immunosuppression. The oncologist decides to start prophylactic treatment to prevent Pneumocystis jirovecii pneumonia (PJP), a common opportunistic infection in immunocompromised patients. Which of the following drug is used for prophylaxis against Pneumocystis jiroveci in patients on chemotherapy?&nbsp;</span></p>",
      "unique_key": "Q3383279",
      "question_audio": null,
      "question_video": null,
      "map_id": 36339,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\"><span style=\"color:black\">Ans. A. Cotrimoxazole</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:16px\"><strong>Cotrimoxazole (trimethoprim-sulfamethoxazole)</strong> is the <strong>drug of choice</strong> for <strong>prophylaxis against Pneumocystis jirovecii pneumonia (PJP) </strong>in patients undergoing<strong> chemotherapy </strong>or those who are otherwise<strong> immunocompromised</strong>. It is<strong> highly effective at preventing PJP </strong>and is also used in the <strong>treatment of active infections</strong>. The standard prophylactic regimen involves taking a<strong> low dose of the medication on a regular schedule</strong> (e.g.,<strong> daily or thrice weekly), </strong>which significantly<strong> reduces the risk of PJP.</strong></span></p>\r\n\r\n<h3><strong><span style=\"font-size:16px\">Explanation of Other Options:</span></strong></h3>\r\n\r\n<p><span style=\"font-size:16px\"><strong>Amoxicillin</strong>: Amoxicillin is a <strong>broad-spectrum antibiotic</strong> commonly used to treat a variety of <strong>bacterial infections</strong>, including <strong>respiratory, urinary tract, and skin infections</strong>. However, it is <strong>not effective against Pneumocystis jirovecii</strong> and is <strong>not used </strong>for<strong> prophylaxis in immunocompromised patients.</strong></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><strong>Dexamethasone</strong>: Dexamethasone is a <strong>corticosteroid used</strong> for its<strong> anti-inflammatory and immunosuppressive</strong> properties. It is <strong>used </strong>in the treatment of various conditions, including <strong>allergic reactions, asthma, and certain types of</strong> <strong>cancer</strong>. While dexamethasone can<strong> reduce inflammation</strong> and manage symptoms in certain contexts, it <strong>does not</strong> have <strong>antimicrobial activity</strong> and is<strong> not </strong>used for <strong>preventing Pneumocystis jirovecii infections.</strong></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><strong>Cephalosporin</strong>: Cephalosporins are a <strong>class of antibiotics </strong>used to treat a<strong> wide range of bacterial infections</strong>, including <strong>respiratory tract infections, skin infections, and urinary tract infections. </strong>Although they are <strong>effective against </strong>many <strong>types of bacteria,</strong> they<strong> do not</strong> provide <strong>prophylaxis against Pneumocystis jirovecii</strong> and are<strong> not </strong>indicated for this purpose in<strong> immunocompromised patients.</strong></span></p>\r\n\r\n<h3><strong><span style=\"font-size:16px\">Educational Objective:</span></strong></h3>\r\n\r\n<p><span style=\"font-size:16px\"><strong>Cotrimoxazole</strong> is the recommended<strong> drug for prophylaxis against Pneumocystis jirovecii pneumonia</strong> in patients <strong>undergoing chemotherapy </strong>or those with <strong>compromised immune systems.</strong></span></p>",
      "correct_choice_id": 50718,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12660,
      "choices": [
        {
          "id": 50602,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ceftriaxone</span></span></span></p>"
        },
        {
          "id": 50603,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin</span></span></span></p>"
        },
        {
          "id": 50604,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Meropenem</span></span></span></p>"
        },
        {
          "id": 50605,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbenicillin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What alternative drug can be used to manage streptococcal endocarditis in a patient who develops an immediate allergy following penicillin administration and is susceptible to it?</span></span></span></p>",
      "unique_key": "Q9452464",
      "question_audio": null,
      "question_video": null,
      "map_id": 36360,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Vancomycin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Vancomycin</strong> is a suitable<strong> alternative for treating streptococcal endocarditis </strong>in patients who are<strong> allergic to penicillin.</strong> As a <strong>glycopeptide antibiotic</strong>, <strong>vancomycin is effective against a wide range of Gram-positive bacteria, </strong>including <strong>Streptococcus species</strong> <strong>responsible for endocarditis. </strong>Its mode of action involves <strong>inhibiting cell wall synthesis,</strong> which is crucial for<strong> bacterial survival and</strong> <strong>proliferation.</strong> Given<strong> its efficacy and the safety profile</strong> in patients<strong> with penicillin allergies</strong>, <strong>vancomycin</strong> is often the preferred <strong>choice in</strong> such<strong> clinical scenarios.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Ceftriaxone</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While ceftriaxone is a <strong>broad-spectrum cephalosporin</strong> used in treating <strong>many bacterial infections</strong>, its use in patients with a known <strong>immediate allergy to penicillin </strong>can be <strong>risky </strong>due to the potential for <strong>cross-reactivity between penicillins and</strong> <strong>cephalosporins</strong>, especially in those with a <strong>history of severe allergic reactions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Meropenem</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This <strong>carbapenem antibiotic is not</strong> typically indicated for <strong>streptococcal endocarditis</strong>, mainly because its <strong>spectrum of action is broader </strong>than necessary for this <strong>type of infection,</strong> and it&rsquo;s <strong>not</strong> a <strong>standard treatment for endocarditis </strong>caused by <strong>Streptococcus.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Carbenicillin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Similar to meropenem</strong>, <strong>carbenicillin</strong> is <strong>not </strong>commonly used to treat <strong>endocarditis due to Streptococcus </strong>and is less relevant in the context of a<strong> penicillin allergy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of<strong> streptococcal endocarditis</strong> where the patient has a<strong> penicillin allergy, vancomycin is a highly effective alternative.</strong> It provides<strong> robust coverage against Gram-positive bacteria </strong>without the <strong>risk of allergic reactions </strong>associated with<strong> beta-lactam</strong> <strong>antibiotics.</strong></span></span></span></p>",
      "correct_choice_id": 50603,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12702,
      "choices": [
        {
          "id": 50770,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ofloxacin</span></span></span></p>"
        },
        {
          "id": 50771,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amikacin</span></span></span></p>"
        },
        {
          "id": 50772,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Penicillin</span></span></span></p>"
        },
        {
          "id": 50773,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ciprofloxacin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs follow time dependent killing?</span></span></span></p>",
      "unique_key": "Q3782018",
      "question_audio": null,
      "question_video": null,
      "map_id": 36342,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Penicillin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Penicillin</strong> exemplifies <strong>time-dependent killing,</strong> a <strong>pharmacodynamic property </strong>where the<strong> efficacy of the drug </strong>is determined by the <strong>duration the plasma concentration of the drug </strong>remains above the <strong>minimum inhibitory concentration (MIC) </strong>of the target pathogen. The therapeutic effectiveness of <strong>time-dependent antibiotics like penicillin </strong>is maximized by <strong>maintaining drug concentrations above</strong> the<strong> MIC</strong> for <strong>as long as</strong> possible during the<strong> dosing interval</strong>. This mode of action <strong>contrasts </strong>with<strong> concentration-dependent killers,</strong> where <strong>efficacy increases </strong>with <strong>higher drug concentrations.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Ofloxacin&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">and <strong>D. Ciprofloxacin</strong>: <strong>Incorrect</strong>. Both of these belong to the<strong> fluoroquinolones class</strong> and follow <strong>concentration-dependent killing,</strong> where their <strong>effectiveness is maximized </strong>when the <strong>peak serum concentration (Cmax) </strong>is significantly <strong>higher than</strong> the <strong>MIC.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Amikacin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Incorrect</strong>. Amikacin is an <strong>aminoglycoside</strong> and also follows <strong>concentration-dependent killing</strong>, where the <strong>killing </strong>effect is<strong> greater</strong> when the <strong>concentration peaks high above the MIC, </strong>typically measured by the<strong> ratio of the peak concentration to the</strong> <strong>MIC (Cmax/MIC).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><u><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture1.jpg\" style=\"height:486px; width:1000px\" /></u></strong></span></span></span></p>",
      "correct_choice_id": 50772,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12747,
      "choices": [
        {
          "id": 50950,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schistosoma haematobium</span></span></span></p>"
        },
        {
          "id": 50951,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diphyllobothrium latum</span></span></span></p>"
        },
        {
          "id": 50952,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beef tapeworm</span></span></span></p>"
        },
        {
          "id": 50953,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neurocysticercosis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">An antihelminthic drug acts on Calcium channels to increase influx and cause spasm in target organisms. This drug is the preferred treatment of choice in all the following except. </span></span></span></p>",
      "unique_key": "Q2822076",
      "question_audio": null,
      "question_video": null,
      "map_id": 36348,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Neurocysticercosis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Praziquantel </strong>is the<strong> antihelminthic drug </strong>described, which works by causing a <strong>rapid influx of calcium into the muscle cells of the</strong> <strong>helminths</strong>, leading to <strong>severe contraction and paralysis of the parasites&#39; muscles.</strong> This mechanism is effective against a<strong> broad</strong> <strong>spectrum of helminths</strong>, including various species of<strong> tapeworms and flukes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Schistosoma haematobium:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Praziquantel </strong>is the <strong>drug of choice for</strong> treating infections caused by this<strong> blood fluke.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Diphyllobothrium latum:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Also<strong> effective</strong> for this <strong>fish tapeworm.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Beef tapeworm:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Effective</strong> for infections caused by <strong>Taenia saginata.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Exception, </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">where praziquantel is not the DOC. These include:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fasciola hepatica (DOC is Triclabendazole)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Echinococcus (DOC is Albendazole)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neurocysticercosis (DOC is Albendazole)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Praziquantel</strong> is effective against most<strong> flukes and tapeworms</strong> but<strong> not</strong> the <strong>first choice for treating neurocysticercosis,</strong> where <strong>Albendazole</strong> is preferred due to its<strong> enhanced effectiveness in the central nervous system.</strong></span></span></span></span></span></span></p>",
      "correct_choice_id": 50953,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12753,
      "choices": [
        {
          "id": 50974,
          "text": "<p><span style=\"font-size:12pt;\">Vancomycin + cefepime + ciprofloxacin.</span></p>"
        },
        {
          "id": 50975,
          "text": "<p><span style=\"font-size:12pt;\">Vancomycin + cefazolin + ciprofloxacin.</span></p>"
        },
        {
          "id": 50976,
          "text": "<p><span style=\"font-size:12pt;\">Telavancin + cefepime + ciprofloxacin.</span></p>"
        },
        {
          "id": 50977,
          "text": "<p><span style=\"font-size:12pt;\">Daptomycin + cefepime + ciprofloxacin.</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 72-year-old male is admitted to the hospital from a nursing home with severe pneumonia. He was recently discharged from the hospital 1 week ago after open heart surgery. The patient has no known allergies. Which of the following regimens is most appropriate for empiric coverage of methicillin resistant Staphylococcus aureus and Pseudomonas aeruginosa in this patient?</span></p>",
      "unique_key": "Q8198274",
      "question_audio": null,
      "question_video": null,
      "map_id": 36353,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A. Vancomycin + cefepime + ciprofloxacin.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>clinical scenario</strong> describes a patient with <strong>severe pneumonia</strong> who is at<strong> risk for methicillin-resistant Staphylococcus</strong> <strong>aureus (MRSA) and Pseudomonas aeruginosa infections.</strong> This<strong> patient</strong> was <strong>recently discharged </strong>from the <strong>hospital after</strong> <strong>open heart surgery, </strong>which puts him at <strong>higher risk for these infections</strong>. Therefore, <strong>empiric antibiotic therapy </strong>should cover <strong>both potential pathogens.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Vancomycin</strong> is a <strong>glycopeptide antibiotic</strong> that is effective <strong>against MRSA.</strong> Treatment of Pseudomonas usually require two antimicrobials effective against this organism. Cefepime is a<strong> fourth-generation cephalosporin</strong> that has activity <strong>against Pseudomonas aeruginosa</strong>, as well as <strong>other gram-negative bacteria</strong>. <strong>Ciprofloxacin </strong>is a <strong>fluoroquinolone antibiotic </strong>that has activity <strong>against Pseudomonas aeruginosa,</strong> as well as <strong>other gram-negative bacteria.</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Therefore, the most <strong>appropriate empiric antibiotic regimen</strong> for this patient would be <strong>vancomycin + cefepime +</strong> <strong>ciprofloxacin, </strong>as described in option A.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong> Which includes<strong> cefazolin instead of cefepime</strong>, would<strong> not</strong> provide adequate<strong> coverage against Pseudomonas aeruginosa.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C: </strong>Includes<strong> telavancin instead of vancomycin,</strong> is<strong> not </strong>necessary as there is<strong> no known allergy to vancomycin</strong>, and <strong>vancomycin</strong> is a <strong>well-established treatment for MRSA infections.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D: </strong>Includes <strong>daptomycin instead of vancomycin, </strong>is <strong>not </strong>effective the<strong> empiric treatment of pneumonia</strong> as it is<strong> inactivated by</strong> <strong>pulmonary surfactant </strong>and further it has<strong> potential adverse effects</strong>, such as<strong> myopathy and rhabdomyolysis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">For a patient with<strong> severe pneumonia </strong>and a <strong>high risk of MRSA and Pseudomonas infection,</strong> an <strong>empirical antibiotic regimen</strong> of <strong>vancomycin, cefepime, and ciprofloxacin</strong> provides<strong> broad and effective coverage,</strong> addressing<strong> both gram-positive and gram-negative pathogens, including resistant strains.</strong></span></p>",
      "correct_choice_id": 50974,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12765,
      "choices": [
        {
          "id": 51022,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clindamycin</span></span></span></p>"
        },
        {
          "id": 51023,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin</span></span></span></p>"
        },
        {
          "id": 51024,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Azithromycin</span></span></span></p>"
        },
        {
          "id": 51025,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linezolid</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following antibiotics is a glycopeptide? </span></span></span></p>",
      "unique_key": "Q7984834",
      "question_audio": null,
      "question_video": null,
      "map_id": 36356,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Vancomycin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Vancomycin</strong> is a well-known<strong> glycopeptide antibiotic</strong> primarily used to<strong> treat serious infections</strong> caused by<strong> Gram-positive</strong> <strong>bacteria</strong>, especially those <strong>resistant to other antibiotics.</strong> Its mode of action involves <strong>inhibiting cell wall synthesis </strong>by <strong>binding to the D-alanyl-D-alanine terminus of cell wall precursor units</strong>. This makes it <strong>particularly effective against MRSA</strong> (methicillin-resistant Staphylococcus aureus) and other <strong>drug-resistant bacterial strains.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Important drugs in this group include:</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Teicoplanin</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Telavancin</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dalbavancin</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oritavancin</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Teicoplanin, Telavancin, Dalbavancin, Oritavancin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Like<strong> Vancomycin</strong>, these are <strong>glycopeptides </strong>used to manage <strong>complex</strong> <strong>infections </strong>due to their<strong> potent efficacy against resistant Gram-positive pathogens.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Clindamycin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a <strong>lincosamide antibiotic</strong>, <strong>effective</strong> <strong>against anaerobic bacteria</strong> and <strong>certain protozoans</strong>, not a glycopeptide.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Azithromycin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Belongs to the <strong>macrolide class of antibiotics</strong>, known for <strong>treating respiratory infections, skin infections, and sexually transmitted infections.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Linezolid:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Although effective<strong> against Gram-positive bacteria,</strong> <strong>Linezolid</strong> is a member of the <strong>oxazolidinone class</strong>, not a glycopeptide.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Vancomycin </strong>is a key representative of<strong> glycopeptide antibiotics,<strong> </strong>used </strong>primarily for <strong>serious infections</strong> caused by <strong>resistant Gram-positive bacteria</strong>. It is<strong> essential</strong> for treating conditions where<strong> other antibiotics have failed due to resistance issues.</strong></span></span><strong> </strong></span></span></span></span></p>",
      "correct_choice_id": 51023,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12794,
      "choices": [
        {
          "id": 51138,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoniazid.</span></span></span></p>"
        },
        {
          "id": 51139,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifampin.</span></span></span></p>"
        },
        {
          "id": 51140,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyrazinamide.</span></span></span></p>"
        },
        {
          "id": 51141,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethambutol.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old male has returned to the clinic for his 1-month check-up after starting treatment for tuberculosis. He is receiving isoniazid, rifampin, pyrazinamide, and ethambutol. He states he feels fine, but now is having difficulty reading his morning newspaper and feels he may need to get glasses. Which of the following drugs may be causing his decline in vision?</span></span></span></p>",
      "unique_key": "Q1359719",
      "question_audio": null,
      "question_video": null,
      "map_id": 36363,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Ethambutol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ethambutol</strong> is known for its potential to<strong> cause optic neuritis, </strong>which can manifest as a <strong>decline in visual acuity and loss of color vision,</strong> particularly<strong> red-green color discrimination.</strong> This side effect is <strong>dose-related and tends to be more common </strong>in patients with <strong>reduced renal function, </strong>where the <strong>drug may accumulate to toxic levels.</strong> If<strong> ethambutol is discontinued promptly </strong>upon the<strong> first signs</strong> of <strong>visual impairment</strong>, the effects are generally <strong>reversible over weeks to months.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Isoniazid:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While isoniazid can cause<strong> peripheral neuropathy</strong>, it is not typically associated with visual disturbances.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Rifampin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Known for causing <strong>hepatotoxicity and reddish-orange discoloration of body fluids,</strong> but it does not usually affect vision.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Pyrazinamide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Can cause <strong>hyperuricemia and hepatotoxicity</strong>, but like the others listed, it <strong>does not </strong>typically lead to <strong>visual</strong> <strong>issues.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Optic neuritis</strong>, exhibited as a<strong> decrease in visual acuity or loss of color discrimination</strong>, is the most important <strong>side effect</strong> associated with <strong>ethambutol. Visual disturbances</strong> generally are<strong> dose related </strong>and more common in<strong> patients with reduced renal function</strong>. They are<strong> reversible (weeks to months) </strong>if <strong>ethambutol is discontinued promptly.</strong></span></span></span></p>",
      "correct_choice_id": 51141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12662,
      "choices": [
        {
          "id": 50610,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Area under curve decreases by 15%</span></span></span></p>"
        },
        {
          "id": 50611,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Area under curve decreases by 35%</span></span></span></p>"
        },
        {
          "id": 50612,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Area under curve increases by 15%</span></span></span></p>"
        },
        {
          "id": 50613,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Area under curve increases by 35%</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old patient with HIV infection is receiving treatment with ritonavir. The patient is now diagnosed with tuberculosis and requires treatment with rifampicin. What is the effect of co-administration of rifampicin and ritonavir on the plasma concentration vs time graph of ritonavir in this patient?</span></span></span></p>",
      "unique_key": "Q5722498",
      "question_audio": null,
      "question_video": null,
      "map_id": 36361,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Area Under Curve decreases by 35%&nbsp;&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> co-administration of rifampicin</strong>, a potent inducer of the <strong>cytochrome P450 (CYP450) enzyme system,</strong> particularly <strong>CYP3A4,</strong> with <strong>ritonavir</strong>, which is metabolized by the same enzyme, results in <strong>increased metabolism of ritonavir. </strong>This interaction significantly<strong> lowers</strong> the<strong> plasma levels of ritonavir</strong> by reducing its area under the <strong>curve (AUC) </strong>by approximately <strong>35%</strong>. This <strong>reduction in AUC </strong>indicates a <strong>decrease in the total drug exposure over time</strong>, which can lead to a<strong> reduction in the drug&#39;s effectiveness</strong> in treating <strong>HIV infection.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifampicin&#39;s effect</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: By enhancing the <strong>activity of CYP3A4, </strong>rifampicin <strong>speeds up the breakdown of ritonavir,</strong> thereby <strong>decreasing its blood concentration </strong>and potentially its <strong>effectiveness in controlling HIV.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical implications: Such a significant<strong> interaction </strong>necessitates adjustments in the dosing of<strong> ritonavir</strong> or possibly using alternative medications that <strong>do not interact </strong>as profoundly with <strong>rifampicin to maintain therapeutic drug levels </strong>and ensure <strong>effective treatment of both HIV and tuberculosis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When treating a patient with<strong> both HIV and tuberculosis,</strong> the interaction between <strong>rifampicin and ritonavir</strong> must be<strong> carefully</strong> <strong>managed</strong>. <strong>Ritonavir&#39;s effectiveness </strong>can be significantly<strong> reduced due to the induction of the CYP450 enzyme by rifampicin,</strong> leading to a <strong>substantial decrease in the drug&#39;s plasma concentration,</strong> as indicated by a <strong>35% reduction in the AUC.</strong> <strong>Adjustments in therapy</strong> or <strong>close monitoring of drug levels</strong> may be required to <strong>maintain efficacy.</strong></span></span><strong> </strong></span></span></span></span></p>",
      "correct_choice_id": 50611,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12668,
      "choices": [
        {
          "id": 50634,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of cell wall synthesis</span></span></span></p>"
        },
        {
          "id": 50635,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alteration of cell membrane integrity</span></span></span></p>"
        },
        {
          "id": 50636,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of protein synthesis</span></span></span></p>"
        },
        {
          "id": 50637,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of transcription</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The mechanism of action of vancomycin is. </span></span></span></p>",
      "unique_key": "Q1041395",
      "question_audio": null,
      "question_video": null,
      "map_id": 36364,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A.</span> </strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inhibition of cell wall synthesis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Vancomycin</strong>, a <strong>glycopeptide antimicrobial agent,</strong> acts primarily by <strong>inhibiting the synthesis of the bacterial cell wall. </strong>It specifically <strong>blocks </strong>the incorporation of<strong> disaccharide pentapeptide subunits</strong> into the <strong>nascent peptidoglycan layer of bacterial cell walls</strong>. It achieves this by <strong>inhibiting the enzyme transglycosylase, </strong>which is crucial for the <strong>polymerization process of the cell wall building</strong> <strong>blocks</strong>. This mode of action results in<strong> weakened cell walls,</strong> ultimately leading to<strong> bacterial cell lysis and death,</strong> particularly in <strong>actively</strong> <strong>dividing cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Alteration of cell membrane integrity</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Incorrect.</strong> <strong>Vancomycin&#39;s</strong> action is specific to <strong>cell wall synthesis</strong> and <strong>does not </strong>directly involve mechanisms that <strong>alter cell membrane integrity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Inhibition of protein synthesis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Incorrect.</strong> Vancomycin <strong>does not</strong> interfere with <strong>protein synthesis;</strong> antibiotics such as <strong>tetracyclines and macrolides </strong>target this pathway.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Inhibition of transcription</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>: Incorrect.</strong> Vancomycin has<strong> no known effect</strong> on the transcription process within bacteria.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drugs inhibiting cell wall synthesis are:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">F</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">irmly: <strong>F</strong>osfomycin </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">ind to: <strong>B</strong>eta lactams.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bac</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">terial: <strong>Bac</strong>itracin</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">ell: <strong>C</strong>ycloserine</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Va</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ll: <strong>Va</strong>ncomycin</span></span></p>",
      "correct_choice_id": 50634,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12671,
      "choices": [
        {
          "id": 50646,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin and amikacin</span></span></span></p>"
        },
        {
          "id": 50647,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cephalexin and gentamicin</span></span></span></p>"
        },
        {
          "id": 50648,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ampicillin and chloramphenicol</span></span></span></p>"
        },
        {
          "id": 50649,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ciprofloxacin and piperacillin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A postoperative patient developed septicemia and was empirically started on combination chemotherapy by a new resident doctor. However, when the patient did not respond even after 10 days of antibiotics treatment the review of the charts was done. It was found that&nbsp; the resident doctor had started the combination of antibiotics which was mutually antagonistic in action. Which of the following is the most likely combination that was given? </span></span></span></p>",
      "unique_key": "Q4511447",
      "question_audio": null,
      "question_video": null,
      "map_id": 36366,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Ampicillin and chloramphenicol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The combination of<strong> ampicillin and chloramphenicol </strong>is likely to be<strong> antagonistic </strong>and could be the reason for the <strong>lack of response </strong>in the <strong>treatment of septicemia.</strong> <strong>Ampicillin</strong> is a <strong>bactericidal antibiotic</strong> that <strong>kills bacteria by inhibiting cell wall synthesis</strong>, effective particularly <strong>against rapidly dividing organisms.</strong> <strong>Chloramphenicol,</strong> on the other hand, is<strong> bacteriostatic</strong> and works by <strong>inhibiting</strong> <strong>protein synthesis</strong>, which <strong>reduces bacterial growth and replication</strong>. When used together, the <strong>bacteriostatic effect </strong>of chloramphenicol can <strong>counteract the bactericidal activity of ampicillin </strong>by <strong>slowing down bacterial growth</strong>, making it less susceptible to the<strong> killing</strong> <strong>mechanism of ampicillin.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Vancomycin and amikacin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Both are bactericidal </strong>antibiotics and typically <strong>do not exhibit antagonism </strong>when combined; instead, they can act synergistically.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Cephalexin and gentamicin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Both drugs are bactericidal </strong>and often used together to cover a<strong> broad spectrum of bacteria,</strong> typically <strong>without antagonistic effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Ciprofloxacin and piperacillin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are <strong>both bactericidal antibiotics,</strong> and their combination is generally <strong>synergistic</strong>, especially against a<strong> wide range of bacterial pathogens.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Combination of a <strong>bactericidal (ampicillin) and a bacteriostatic drug (chloramphenicol)</strong> is usually <strong>antagonistic in nature.</strong> This is because <strong>cidal drugs</strong> are usually acting on a<strong> fast-multiplying organisms</strong> whereas <strong>static drugs</strong> <strong>decrease this multiplication.</strong> </span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"> </span></span></span></span></p>",
      "correct_choice_id": 50648,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12737,
      "choices": [
        {
          "id": 50910,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synthesizing enzymes against antibiotics</span></span></span></p>"
        },
        {
          "id": 50911,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Altering porin channels</span></span></span></p>"
        },
        {
          "id": 50912,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Actively effluxing the drug out</span></span></span></p>"
        },
        {
          "id": 50913,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Inhibiting DNA gyrase or topoisomerase activity</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following mechanisms is not associated with drug resistance against antimicrobials? </span></span></span></p>",
      "unique_key": "Q2901588",
      "question_audio": null,
      "question_video": null,
      "map_id": 36347,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. By inhibiting DNA gyrase or topoisomerase activity</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inhibiting DNA gyrase or topoisomerase activity </strong>is <strong>not a resistance mechanism</strong> utilized by <strong>bacteria;</strong> instead, it is a<strong> mechanism of</strong> <strong>action used by antibiotics,</strong> specifically<strong> fluoroquinolones,</strong> to exert their<strong> antimicrobial effect.</strong> When<strong> bacteria develop resistance</strong>, they <strong>do not inhibit these enzymes</strong>; rather, they may<strong> alter the target of such antibiotics</strong> so the drug<strong> cannot bind effectively </strong>or may <strong>produce enzymes </strong>that<strong> degrade the antibiotic</strong>,<strong> alter membrane porins,</strong> or <strong>utilize efflux pumps</strong> to <strong>reduce drug concentration within the bacterial cell</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect </strong>because <strong>synthesizing enzymes against antibiotics </strong>is a known <strong>resistance mechanism</strong> where <strong>bacteria produce</strong> <strong>enzymes</strong> that<strong> degrade or modify the antibiotic,</strong> rendering it <strong>ineffective.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect</strong> because <strong>altering porin channels is a resistance mechanism</strong> that <strong>limits the entry of the drug into the bacterial cell,</strong> <strong>reducing </strong>its<strong> intracellular concentration and effectiveness.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect</strong> because <strong>actively effluxing the drug out</strong> is a <strong>resistance mechanism </strong>where<strong> bacteria use efflux pumps to remove</strong> the<strong> antibiotic from the cell,</strong> <strong>reducing its efficacy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The following are mechanisms of drug resistance against antimicrobials:</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture21.jpg\" style=\"height:372px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 50913,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12749,
      "choices": [
        {
          "id": 50958,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">I, II and III</span></span></span></p>"
        },
        {
          "id": 50959,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">I and II</span></span></span></p>"
        },
        {
          "id": 50960,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">II and IV</span></span></span></p>"
        },
        {
          "id": 50961,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">I, II, III and IV</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antimicrobial resistance to which of the following drugs develop by synthesis of inactivating enzymes? </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol start=\"1\" style=\"list-style-type:upper-roman\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aminoglycosides</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta lactams</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chloramphenicol</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluoroquinolones</span></span></span></li>\r\n</ol>",
      "unique_key": "Q5082229",
      "question_audio": null,
      "question_video": null,
      "map_id": 36350,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. I, II and III </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Antimicrobial resistance</strong> through the <strong>synthesis of inactivating enzymes</strong> is a major mechanism by which <strong>bacteria</strong> evade the<strong> effects of</strong> <strong>antibiotics</strong>. These enzymes <strong>chemically modify the drug molecule</strong>, rendering it<strong> inactive against the bacteria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aminoglycosides:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Resistance</strong> occurs via enzymes that<strong> modify the drug, </strong>typically by <strong>phosphorylation, adenylylation, or</strong> <strong>acetylation.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta lactams:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Enzymes such as <strong>beta-lactamases cleave the beta-lactam ring,</strong> <strong>deactivating</strong> the<strong> drug&rsquo;s antibacterial</strong> <strong>activity.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chloramphenicol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Enzymatic inactivation </strong>occurs via <strong>acetylation, </strong>which <strong>prevents the drug from binding to the bacterial ribosome.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluoroquinolones (IV)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are<strong> not </strong>typically<strong> inactivated by enzymes</strong>; instead,<strong> resistance often develops</strong> through <strong>mutations</strong> that alter <strong>drug targets or increase drug efflux.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The following are mechanisms of drug resistance against antimicrobials:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture27.jpg\" style=\"height:372px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 50958,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12751,
      "choices": [
        {
          "id": 50966,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gentamicin</span></span></p>"
        },
        {
          "id": 50967,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Penicillin G.</span></span></span></p>"
        },
        {
          "id": 50968,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin.</span></span></span></p>"
        },
        {
          "id": 50969,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aztreonam.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following antibiotics exhibits a long post-antibiotic effect that permits once-daily dosing?</span></span></span></p>",
      "unique_key": "Q9352666",
      "question_audio": null,
      "question_video": null,
      "map_id": 36351,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Gentamicin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> post-antibiotic effect (PAE)</strong> is the continued<strong> suppression of bacterial growth</strong> even after the<strong> antibiotic concentration</strong> falls below the<strong> minimum inhibitory concentration (MIC) </strong>of the organism. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> longer the PAE</strong>, the<strong> longer the interval between doses </strong>can be <strong>without compromising the efficacy of the antibiotic.</strong> <strong>Gentamicin </strong>is an aminoglycoside antibiotic that <strong>exhibits a long PAE</strong>, which allows for<strong> once-daily dosing.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Once-daily dosing</strong> of<strong> gentamicin </strong>has been shown to be as<strong> effective as multiple daily dosing</strong> for the treatment of <strong>serious</strong> <strong>bacterial infections</strong>, such as <strong>sepsis and endocarditis. </strong>This<strong> dosing regimen</strong> also has the advantage of<strong> reducing the risk of</strong> <strong>toxicity associated with aminoglycosides,</strong> such as <strong>nephrotoxicity and ototoxicity.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Penicillin G:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Thi<strong>s beta-lactam antibiotic</strong> <strong>does not</strong> have a significant PAE, requiring<strong> more frequent dosing</strong> schedules, typically<strong> every 4 to 6 hours</strong>, to<strong> maintain effective blood concentrations.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Vancomycin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> As a <strong>glycopeptide antibiotic,</strong> vancomycin also <strong>lacks a prolonged PAE </strong>and is generally dosed <strong>every 8 to 12</strong> <strong>hours, </strong>depending on the<strong> type and severity of the infection</strong> and the<strong> patient&#39;s renal function.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Aztreonam:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This <strong>monobactam antibiotic</strong> is typically <strong>administered every 8 hours</strong>, reflecting its<strong> shorter PAE </strong>and the need for<strong> more frequent administration </strong>to maintain<strong> therapeutic levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gentamicin&#39;s long post-antibiotic effect</strong> allows for <strong>once-daily dosing, </strong>which is <strong>beneficial</strong> in managing<strong> severe infections </strong>while <strong>reducing the risk of toxicity</strong> associated with <strong>more frequent dosing</strong>. This makes it an<strong> effective choice for treatments</strong> where<strong> high peak</strong> <strong>concentrations</strong> and<strong> less frequent dosing </strong>are <strong>desirable.</strong></span></span></span></span></span></span></p>",
      "correct_choice_id": 50966,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12752,
      "choices": [
        {
          "id": 50970,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ivermectin</span></span></span></p>"
        },
        {
          "id": 50971,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyrantel pamoate</span></span></span></p>"
        },
        {
          "id": 50972,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albendazole</span></span></span></p>"
        },
        {
          "id": 50973,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diethylcarbamazine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 48-year-old immigrant from Mexico presents with seizures and other neurologic symptoms. Eggs of T. solium are found upon examination of a stool specimen. A magnetic resonance image of the brain shows many cysts, some of which are calcified. Which one of the following drugs would be of benefit to this individual? </span></span></span></p>",
      "unique_key": "Q5849492",
      "question_audio": null,
      "question_video": null,
      "map_id": 36352,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Albendazole</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>clinical scenario </strong>describes a patient with <strong>neurocysticercosis </strong>caused by<strong> Taenia solium,</strong> which is a <strong>parasitic infection</strong> of the<strong> central nervous system</strong>. <strong>Neurocysticercosis</strong> is a serious condition that can <strong>cause seizures, headaches, and other</strong> <strong>neurological symptoms.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Albendazole</strong> is the <strong>drug of choice </strong>for the treatment of<strong> neurocysticercosis</strong>. It is a <strong>broad-spectrum anthelmintic agent</strong> that is <strong>effective against a variety of parasitic infections,</strong> including<strong> neurocysticercosis.</strong> It works by <strong>inhibiting the</strong> <strong>formation of microtubules</strong> in the parasite, which ultimately<strong> leads to its death.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Ivermectin </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an<strong> antiparasitic agent </strong>that is <strong>effective against </strong>a variety of<strong> parasitic infections, </strong>but it is<strong> not</strong> the drug of choice for the treatment of<strong> neurocysticercosis</strong>. It is<strong> more commonly used for</strong> the treatment of <strong>onchocerciasis (river blindness) and</strong> <strong>lymphatic filariasis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Pyrantel pamoate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is an anthelmintic agent that is <strong>effective against intestinal nematodes, </strong>such as<strong> Ascaris lumbricoides and Enterobius vermicularis,</strong> but it is not effective against neurocysticercosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Diethylcarbamazine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is an <strong>antiparasitic agent</strong> that is <strong>effective against filarial infections,</strong> such as<strong> lymphatic filariasis</strong> and <strong>loiasis,</strong> but it is not effective against neurocysticercosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Albendazole</strong> is the preferred treatment for<strong> neurocysticercosis</strong>, <strong>targeting the cysts</strong> formed by the<strong> larval stage of <em>Taenia solium</em> </strong>in the <strong>brain,</strong> effectively <strong>reducing the neurological symptoms </strong>associated with the<strong> disease.</strong></span></span></span></p>",
      "correct_choice_id": 50972,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12809,
      "choices": [
        {
          "id": 51198,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radical cure of P.vivax</span></span></span></p>"
        },
        {
          "id": 51199,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prophylaxis of malaria in pregnancy</span></span></span></p>"
        },
        {
          "id": 51200,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment of severe falciparum malaria</span></span></span></p>"
        },
        {
          "id": 51201,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment in children &lt; 2 years</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tafenoquine is a recently approved new drug. It is indicated for?</span></span></span></p>",
      "unique_key": "Q1668481",
      "question_audio": null,
      "question_video": null,
      "map_id": 36334,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Radical cure of P. vivax</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tafenoquine, </strong>which is a<strong> new antimalarial drug,</strong> has been approved specifically for the <strong>radical cure of Plasmodium vivax</strong>. The term <strong>&quot;radical cure&quot;</strong> refers to the <strong>elimination of all forms of the parasite,</strong> including <strong>dormant liver stages known as hypnozoites,</strong> which are responsible for the<strong> relapsing nature of P. vivax malaria.</strong> <strong>Tafenoquine&#39;s</strong> approval by the <strong>US FDA</strong> in 2018 marked a significant step in the <strong>fight against </strong>this form of <strong>malaria</strong>, providing a<strong> new option</strong> for patients, including those <strong>aged 16 years</strong> and <strong>older.</strong> As a <strong>single-dose</strong> therapy, <strong>tafenoquine </strong>offers an advantage in terms of <strong>adherence over </strong>the<strong> standard primaquine therapy</strong>, which requires a<strong> 14-day</strong> <strong>course.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Prophylaxis of malaria in pregnancy: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>not </strong>an <strong>indication for tafenoquine,</strong> as it can cause <strong>hemolysis in patients</strong> with <strong>G-6-PD deficiency, </strong>a condition that<strong> canno</strong>t be ruled out in the<strong> fetus,</strong> making it<strong> contraindicated during pregnancy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Treatment of severe falciparum malaria</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Tafenoquine is <strong>not </strong>indicated for the<strong> treatment of severe falciparum malaria</strong>, where other medications such as<strong> intravenous artesunate</strong> are the treatments of choice.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Treatment in children &lt; 2 years: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The drug is <strong>not </strong>approved for use in<strong> children under the age of 16 </strong>due to the<strong> lack of safety</strong> <strong>data and the risk of hemolysis</strong>, especially in those with <strong>G-6-PD deficiency.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tafenoquine </strong>is a valuable addition to the <strong>antimalarial arsenal,</strong> especially for the <strong>radical cure of P. vivax, </strong>which is <strong>notorious </strong>for <strong>causing relapses.</strong> However, it must be used <strong>cautiously</strong> considering its<strong> contraindications, </strong>including <strong>G-6-PD deficiency, pregnancy, </strong>and <strong>age restrictions.</strong></span></span></span></p>",
      "correct_choice_id": 51198,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12685,
      "choices": [
        {
          "id": 50702,
          "text": "<p><span style=\"color:#000000; font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><em>A</em></span></span></p>"
        },
        {
          "id": 50703,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">B</span></span></span></span></p>"
        },
        {
          "id": 50704,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">C</span></span></span></span></p>"
        },
        {
          "id": 50705,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">D</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Some gram-negative bacteria produce an enzyme that blocks the action of beta lactam antibiotics in periplasmic space. Which arrow in the structural diagram of Penicillin G denotes the site of action of this enzyme? </span></span></span></p>\r\n\r\n<p style=\"margin-left:0; margin-right:0; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:0; margin-right:0; text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/04/picture7_VTwbCI2.jpg\" style=\"height:170px; width:300px\" /></p>",
      "unique_key": "Q7193634",
      "question_audio": null,
      "question_video": null,
      "map_id": 36336,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. B</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-lactamases </strong>are enzymes that confer <strong>resistance to beta-lactam antibiotics</strong> by <strong>breaking down their chemical structure.</strong> They target the<strong> amide bond </strong>within the<strong> beta-lactam ring</strong>&mdash;a <strong>four-membered ring structure</strong> within the antibiotic molecule. This ring is crucial for the <strong>antibiotic&#39;s activity</strong>, as it allows the drug to <strong>inhibit the synthesis of the bacterial cell wall</strong>. By <strong>hydrolyzing </strong>the bond at the<strong> beta-lactam ring, beta-lactamases</strong> prevent the <strong>antibiotic from performing its function, leading to resistance. </strong>The arrow marked <strong>&quot;B&quot; points</strong> to th<strong>e beta-lactam ring </strong>where this <strong>enzymatic action occurs.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Incorrect</strong> because it points to a part of the molecule that is <strong>not </strong>involved in the<strong> action of beta-lactamase enzymes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Incorrect</strong> as it <strong>does not point </strong>to the <strong>beta-lactam ring </strong>but to a side chain that <strong>does not</strong> affect the<strong> primary action of beta-lactamase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. D</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Incorrect because</strong> this part of the molecule is <strong>not the beta-lactam ring</strong> and is therefore <strong>not the site of action for beta-lactamase enzymes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The key to understanding <strong>the resistance mechanism against beta-lactam antibiotics like Penicillin G</strong> is recognizing the role of <strong>beta-lactamase enzymes.</strong> These <strong>enzymes deactivate the antibiotic by hydrolyzing the crucial beta-lactam ring, </strong>which is necessary for the <strong>drug&#39;s antibacterial action</strong>. The <strong>beta-lactam ring&#39;s integrity </strong>is essential for the<strong> antibiotic to exert its effect on bacteria,</strong> and its <strong>disruption leads to antibiotic resistance.</strong></span></span></span></span></span></span></p>",
      "correct_choice_id": 50703,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12704,
      "choices": [
        {
          "id": 50778,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Penicillin G</span></span></span></p>"
        },
        {
          "id": 50779,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clindamycin</span></span></span></p>"
        },
        {
          "id": 50780,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cephalexin</span></span></span></p>"
        },
        {
          "id": 50781,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quinupristin and dalfopristin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the first line drug for the treatment of toxic shock syndrome?</span></span></span></p>",
      "unique_key": "Q6458589",
      "question_audio": null,
      "question_video": null,
      "map_id": 36343,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Clindamycin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Clindamycin </strong>is considered a<strong> first-line</strong> treatment for <strong>toxic shock syndrome (TSS), </strong>primarily because of its ability to <strong>inhibit bacterial</strong> <strong>protein synthesis</strong>, including the<strong> production of toxins</strong> that are critical to the <strong>pathogenesis of TSS. </strong>TSS is most commonly <strong>associated</strong> with<strong> toxin-producing strains of <em>Staphylococcus aureus</em>,</strong> and<strong> clindamycin&rsquo;s mechanism </strong>of i<strong>nhibiting toxin production </strong>makes it particularly effective. This action helps <strong>reduce the levels of circulating toxins </strong>that contribute to the severe symptoms of TSS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Penicillin G</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Incorrect.</strong> While <strong>effective against many bacterial infections,</strong> <strong>Penicillin G</strong> is <strong>not the first choice</strong> for <strong>TSS,</strong> especially due to concerns about <strong>resistance and its ineffectiveness</strong> in <strong>inhibiting toxin production.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Cephalexin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Incorrect</strong>. Like <strong>Penicillin G</strong>, Cephalexin is a <strong>beta-lactam antibiotic</strong> that is <strong>not effective</strong> in <strong>reducing toxin</strong> <strong>production</strong>, which is crucial in the management of<strong> TSS.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Quinupristin and dalfopristin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Incorrect.</strong> This combination therapy is <strong>reserved for infections</strong> caused by<strong> gram-positive</strong> <strong>bacteria</strong>, including <strong>vancomycin-resistant strains,</strong> but it is not typically the first line for TSS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibiotics for treatment of Toxic shock syndrome (TSS)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>TSS</strong> is usually managed in the<strong> intensive care setting </strong>and the main line of management is supportive management along with <strong>appropriate antibiotic therapy </strong>to <strong>eradicate Staph. aureus </strong>which is mostly the causative organism.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Because of the <strong>increasing frequency of methicillin-resistant Staphylococci </strong>in the community,<strong> Vancomycin </strong>is often <strong>recommended.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta lactamase resistant penicillin&rsquo;s</strong> are<strong> not very effective </strong>due to <strong>emerging resistance</strong> and they may <strong>increase TSST-1</strong> <strong>production in vitro </strong>probably <strong>due to cell lysis</strong>. Hence, if they are prescribed they are usually<strong> prescribed with clindamycin</strong> which <strong>inhibits bacterial protein toxin production.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other treatment options are<strong> linezolid</strong> and a <strong>combination of vancomycin and clindamycin </strong>for suspected serious <strong>staphylococcal infections </strong>pending<strong> culture and sensitivity.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Intravenous immunoglobulin (IVIG;</strong> which presumably acts in part via <strong>neutralizing antibodies against toxins)</strong> has been used and appears to have significant promise. At present, <strong>IVIG is used</strong> in <strong>severe recalcitrant cases.</strong></span></span></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 50779,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12717,
      "choices": [
        {
          "id": 50830,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pre-erythrocytic stage</span></span></span></p>"
        },
        {
          "id": 50831,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erythrocytic stage</span></span></span></p>"
        },
        {
          "id": 50832,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Exo-erythrocytic stage</span></span></span></p>"
        },
        {
          "id": 50833,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypnozoites</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At which stage in the life cycle of malarial parasites does Primaquine act to provide causal prophylaxis?</span></span></span></p>",
      "unique_key": "Q9882356",
      "question_audio": null,
      "question_video": null,
      "map_id": 36345,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Pre-erythrocyte</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Primaquine</strong> is unique among <strong>antimalarial drugs</strong> in that it provides <strong>causal prophylaxis </strong>by acting on the <strong>pre-erythrocytic stage</strong> of the <strong>malaria parasite.</strong> This stage involves the <strong>initial development phases of the parasite </strong>in the<strong> liver cells </strong>immediately after the<strong> infectious</strong> <strong>bite by a mosquito. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">By <strong>targeting this liver stage, Primaquine prevents</strong> the <strong>development of the parasite</strong> <strong>before </strong>it reaches the <strong>bloodstream, </strong>which <strong>stops</strong> the <strong>disease before </strong>it <strong>can start.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Erythrocytic stage</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Incorrect</strong>. <strong>Primaquine</strong> is <strong>not </strong>primarily<strong> effective against the erythrocytic stages</strong>; drugs like<strong> chloroquine</strong> and<strong> artemisinins target these stages.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Exo-erythrocytic stage</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Incorrect</strong> as a specific answer here because it <strong>more broadly </strong>refers to<strong> stages in the liver, </strong>but <strong>not</strong> precisely the <strong>initial pre-erythrocytic development.</strong> <strong>Primaquine also </strong>acts on this <strong>stage </strong>when <strong>targeting hypnozoites for radical cure.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Hypnozoites</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Incorrect</strong> in the context of causal<strong> prophylaxis.</strong> <strong>Hypnozoites</strong> are <strong>dormant liver stage parasites of <em>P. vivax</em> or </strong><em><strong>P.</strong> <strong>ovale</strong></em>, and while<strong> Primaquine does target</strong> these for <strong>radical cure (preventing relapses), </strong>this is <strong>not</strong> considered part of <strong>causal</strong> <strong>prophylaxis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture6.jpg\" style=\"height:722px; width:1000px\" /></span></u></strong></span></span></p>",
      "correct_choice_id": 50830,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12748,
      "choices": [
        {
          "id": 50954,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">I, II and III</span></span></span></p>"
        },
        {
          "id": 50955,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">I and II</span></span></span></p>"
        },
        {
          "id": 50956,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">II and IV</span></span></span></p>"
        },
        {
          "id": 50957,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">I, II, III and IV</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify antipseudomonal cephalosporins out of the following: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol start=\"1\" style=\"list-style-type:upper-roman\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cefepime</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cefpirome</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ceftazidime</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cefoperazone</span></span></span></li>\r\n</ol>",
      "unique_key": "Q2618676",
      "question_audio": null,
      "question_video": null,
      "map_id": 36349,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. I, II, III and IV </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>All</strong> four listed <strong>cephalosporins</strong> &ndash; <strong>Cefepime, Cefpirome, Ceftazidime, and Cefoperazone </strong>&ndash; are known for their <strong>activity against</strong> <strong>Pseudomonas aeruginosa,</strong> making them <strong>antipseudomonal cephalosporins.</strong> These drugs are part of a <strong>broader class of beta-lactam</strong> antibiotics that <strong>have been modified to resist degradation by the bacteria&#39;s beta-lactamases </strong>and to <strong>penetrate the outer membrane</strong> <strong>of Pseudomonas</strong>, effectively <strong>inhibiting cell wall synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Detail on each Cephalosporin:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cefepime (IV):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>fourth-generation cephalosporin,</strong> highly <strong>effective against </strong>a broad range of<strong> Gram-positive and Gram-negative bacteria,</strong> including <strong>Pseudomonas.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cefpirome (IV):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>fourth-generation cephalosporin</strong>, known for its<strong> broad-spectrum </strong>activity, which includes efficacy <strong>against Pseudomonas.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ceftazidime (III):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>third-generation cephalosporin</strong>, specifically<strong> formulated to target Pseudomonas aeruginosa.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cefoperazone (III):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Also a <strong>third-generation cephalosporin</strong>, noted for its <strong>effectiveness against Pseudomonas.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-Pseudomonal Drugs</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture25.jpg\" style=\"height:456px; width:1000px\" /><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture26.jpg\" style=\"height:318px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 50957,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12756,
      "choices": [
        {
          "id": 50986,
          "text": "<p style=\"margin-left:0; margin-right:0\">​​​​​​<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ceftaroline is effective in MRSA.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>"
        },
        {
          "id": 50987,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cefoxitin has no activity against Bacteroides.</span></span></span></p>"
        },
        {
          "id": 50988,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cefotaxime has good CSF penetration.</span></span></span></p>"
        },
        {
          "id": 50989,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ceftazidime is active against Pseudomonas.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">True about Cephalosporins are all except?</span></span></span></p>",
      "unique_key": "Q9482112",
      "question_audio": null,
      "question_video": null,
      "map_id": 36354,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Cefoxitin has no activity against Bacteroides.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The statement about<strong> Cefoxitin is incorrect</strong> as Cefoxitin actually does have <strong>activity against Bacteroides,</strong> particularly <strong>Bacteroides</strong> <strong>fragilis</strong>. It is classified as a <strong>second-generation cephalosporin </strong>known for its<strong> strong anaerobic coverage,</strong> making it effective for infections like i<strong>ntra-abdominal infections</strong> where<strong> Bacteroides species are common pathogens.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Ceftaroline is effective in MRSA.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is <strong>true.</strong> <strong>Ceftaroline</strong> is a<strong> fifth-generation cephalosporin</strong> that is one of the few <strong>cephalosporins effective against MRSA </strong>due to its ability <strong>to bind to altered penicillin-binding proteins</strong> that <strong>MRSA produces.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Cefotaxime has good CSF penetration.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is<strong> true. </strong>Cefotaxime, a<strong> third-generation cephalosporin</strong>, is known for its <strong>excellent penetration into the cerebrospinal fluid,</strong> making it a preferred<strong> choice for treating central nervous system</strong> infections like <strong>meningitis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Ceftazidime is active against Pseudomonas.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is also<strong> true</strong>. <strong>Ceftazidime </strong>is another <strong>third-generation cephalosporin </strong>noted for its activity <strong>against Pseudomonas aeruginosa</strong>, making it valuable for treating infections caused by this challenging pathogen.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cefoxitin is effective against Bacteroides species,</strong> <strong>contradicting </strong>the claim made in<strong> option B.</strong> It is important to understand the <strong>spectrum of activity of cephalosporins </strong>as they <strong>vary greatly across generations</strong> and <strong>individual drugs,</strong> affecting their<strong> suitability for</strong> <strong>different types of bacterial infections.</strong></span></span></span></span></span></span></p>",
      "correct_choice_id": 50987,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12796,
      "choices": [
        {
          "id": 51146,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lopinavir</span></span></span></p>"
        },
        {
          "id": 51147,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Raltegravir</span></span></span></p>"
        },
        {
          "id": 51148,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Didanosine</span></span></span></p>"
        },
        {
          "id": 51149,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Efavirenz</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A person is being treated for Human immunodeficiency virus-1. He developed hypertriglyceridemia and hypercholesterolemia. Most likely drug implicated for these adverse effects is?</span></span></span></p>",
      "unique_key": "Q8229638",
      "question_audio": null,
      "question_video": null,
      "map_id": 36362,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Lopinavir</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lopinavir,</strong> commonly used in<strong> combination with ritonavir (as Lopinavir/ritonavir), </strong>is a<strong> protease inhibitor </strong>used in the treatment of <strong>HIV. Protease inhibitors</strong> are known for <strong>causing several metabolic disturbances, </strong>including<strong> hypertriglyceridemia </strong>and <strong>hypercholesterolemia</strong>. These <strong>effects</strong> are attributed to the <strong>drug&#39;s impact on lipid metabolism,</strong> which can also <strong>lead</strong> to<strong> insulin</strong> <strong>resistance and lipodystrophy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Raltegravir:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> An<strong> integrase inhibitor,</strong> which is generally<strong> not </strong>associated with significant <strong>lipid metabolism disturbances.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Didanosine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>nucleoside reverse transcriptase inhibitor,</strong> known for potential <strong>side effects</strong> like<strong> pancreatitis and peripheral</strong> <strong>neuropathy,</strong> but <strong>less</strong> so for<strong> lipid abnormalities.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Efavirenz:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>non-nucleoside reverse transcriptase inhibitor,</strong> which can cause <strong>some lipid abnormalities</strong> but is<strong> more</strong> commonly associated with <strong>central nervous system side effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lopinavir</strong> is a <strong>protease inhibitor. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>All protease inhibitors</strong> are metabolized by<strong> liver,</strong> and all can cause <strong>metabolic abnormalities </strong>including <strong>hypercholesterolemia, diabetes mellitus, hyperlipidemia, insulin resistance </strong>and <strong>altered fat distribution (lipodystrophy)</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atazanavir</strong> has a <strong>minimum risk</strong> of causing these adverse effects.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tesamorelin</strong> is a <strong>synthetic analogue </strong>of <strong>growth hormone releasing factor</strong> indicated to <strong>reduce excess abdominal fat </strong>in <strong>HIV infected patients</strong> with<strong> lipodystrophy.</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 51146,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12654,
      "choices": [
        {
          "id": 50578,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cotrimoxazole</span></span></span></p>"
        },
        {
          "id": 50579,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amoxicillin</span></span></span></p>"
        },
        {
          "id": 50580,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexarnethasone</span></span></span></p>"
        },
        {
          "id": 50581,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cephalosporin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old patient with a history of cancer is scheduled to start chemotherapy. The oncologist plans to give prophylaxis against Pneumocystis jiroveci pneumonia (PCP). Which drug would be appropriate for this patient?</span></span></span></p>",
      "unique_key": "Q5914753",
      "question_audio": null,
      "question_video": null,
      "map_id": 36357,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Cotrimoxazole</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cotrimoxazole,</strong> known chemically as <strong>trimethoprim-sulfamethoxazole, </strong>stands out as the<strong> drug of choice for both prophylaxis and</strong> <strong>treatment of Pneumocystis jiroveci pneumonia (PCP) </strong>among <strong>both immunocompetent and immunocompromised patients</strong>. This recommendation is particularly <strong>pertinent for patients undergoing chemotherapy</strong> who are inherently at a<strong> heightened risk for PCP, a</strong> fungal infection that can become<strong> life-threatening if not properly managed. </strong>The <strong>effectiveness of Cotrimoxazole in preventing</strong> this <strong>infection </strong>makes it a preferred option over other antibiotics, which lack the necessary activity against this specific pathogen.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Amoxicillin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is primarily a<strong> bacterial antibiotic </strong>and<strong> does not</strong> provide<strong> coverage against fungal infections like PCP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Dexamethasone</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Although useful in <strong>reducing inflammation</strong> and <strong>managing symptoms </strong>in a variety of conditions, dexamethasone is <strong>not an antifungal agent </strong>and thus is <strong>not suitable for preventing PCP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Cephalosporin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These <strong>antibiotics</strong> are also geared <strong>towards bacterial infections</strong> and <strong>do not</strong> act on<strong> fungi,</strong> making them <strong>ineffective for PCP prophylaxis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note &ndash;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> For patients<strong> who cannot tolerate Cotrimoxazole,</strong> alternatives like <strong>pentamidine or atovaquone</strong> might be considered. These are also <strong>effective against PCP </strong>but are generally <strong>reserved for cases</strong> where <strong>Cotrimoxazole cannot</strong> be used due to <strong>adverse reactions or</strong> <strong>contraindications.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cotrimoxazole</strong> is the preferred <strong>choice for preventing Pneumocystis jiroveci pneumonia </strong>in patients with<strong> compromised immune</strong> <strong>systems</strong>, such as those <strong>undergoing chemotherapy,</strong> due to its <strong>effective antifungal properties</strong> specifically<strong> targeting this pathogen.</strong></span></span></span></p>",
      "correct_choice_id": 50578,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12676,
      "choices": [
        {
          "id": 50666,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">These can hydrolyze penicillins, cephalosporins as well as monobactams</span></span></span></p>"
        },
        {
          "id": 50667,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbapenems are sensitive to ESBL</span></span></span></p>"
        },
        {
          "id": 50668,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amber classification of ESBL is based on structural differences</span></span></span></p>"
        },
        {
          "id": 50669,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Third and fourth generation cephalosporins are used for detection of ESBL</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is false about extended spectrum beta- lactamases (ESBL)?</span></span></span></p>",
      "unique_key": "Q4670726",
      "question_audio": null,
      "question_video": null,
      "map_id": 36333,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Carbapenems Are sensitive to ESBL</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carbapenems</strong> are usually considered the<strong> first-line treatment for infections</strong> caused by <strong>ESBL-producing bacteria,</strong> as they are<strong> not</strong> <strong>affected by ESBL</strong>. Read the statement carefully. Here it is written that <strong>carbapenems are sensitive to ESBL,</strong> it means they can be <strong>broken by ESBL </strong>which is wrong as they are <strong>resistant to ESBL</strong>. On the other hand the <strong>correct statement</strong> would have been <strong>ESBL</strong> <strong>producing bacteria are sensitive to carbapenems.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></strong> <strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">These can hydrolyze penicillins, cephalosporins as well as monobactams:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Correct.</strong> ESBL are enzymes produced by some bacteria that can <strong>hydrolyze penicillins,</strong> <strong>cephalosporins, and monobactams</strong>. This can lead to <strong>resistance to many beta-lactam</strong> <strong>antibiotics</strong>, including<strong> third- and fourth generation cephalosporins and aztreonam, a monobactam. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong> <strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amber classification of ESBL is based on structural differences</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Correct</strong>. he Amber classification of ESBL is based on <strong>structural differences in the beta-lactamase enzymes</strong>, which can affect their <strong>spectrum of activity and ability to be inhibited by beta-lactamase inhibitors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong> <strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Third and fourth generation cephalosporins are used for detection of ESBL</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> </strong></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Correct. Third- and fourth generation</strong> cephalosporins, such as <strong>cefotaxime, ceftazidime, and cefepime,</strong> are commonly used for the <strong>detection of ESBL.</strong> This is done by performing a <strong>susceptibility test</strong> with the<strong> antibiotic alone,</strong> and then <strong>repeating the test in the presence of a beta-lactamase inhibitor,</strong> such as<strong> clavulanic acid. </strong>A significant<strong> increase in susceptibility </strong>to the <strong>antibiotic in the presence of the inhibitor indicates</strong> the presence of an <strong>ESBL.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carbapenems are not sensitive </strong>to <strong>ESBL-producing enzymes</strong> but are instead a critical treatment option for<strong> infections caused </strong>by these <strong>resistant bacteria</strong>. Understanding the <strong>properties of ESBL</strong> and the <strong>effectiveness of carbapenems against </strong>them is <strong>essential </strong>for appropriately<strong> managing bacterial infections</strong> that <strong>exhibit extended-spectrum beta-lactamase resistance.</strong></span></span></span></span></span></span></p>",
      "correct_choice_id": 50667,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12687,
      "choices": [
        {
          "id": 50710,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bedaquiline</span></span></span></p>"
        },
        {
          "id": 50711,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linezolid</span></span></span></p>"
        },
        {
          "id": 50712,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluconazole</span></span></span></p>"
        },
        {
          "id": 50713,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liposomal amphotericin B</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old male had fever for the past 1 week with abdominal distention and loss of appetite. It is not responding to antibiotics and antimalarials. Widal test is negative but RK39 dipstick test is positive. Which of the following drugs can be used in the above patient? </span></span></span></p>",
      "unique_key": "Q2776452",
      "question_audio": null,
      "question_video": null,
      "map_id": 36337,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Liposomal amphotericin B</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s symptoms, coupled with a <strong>negative Widal test and a positive RK39 dipstick test,</strong> suggest a diagnosis of<strong> visceral</strong> <strong>leishmaniasis,</strong> also known as<strong> kala-azar.</strong> This disease is caused by the<strong> Leishmania donovani complex, </strong>a parasitic <strong>protozoan.</strong> <strong>Liposomal amphotericin B </strong>is the <strong>drug of choice</strong> for this condition. This formulation of <strong>amphotericin B</strong> enhances drug delivery to the <strong>infected cells</strong>, <strong>reduces the drug&rsquo;s toxicity, </strong>and is<strong> effective against the parasites</strong> causing <strong>leishmaniasis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Bedaquiline</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>: Incorrect for leishmaniasis.</strong> Bedaquiline is used for the treatment of <strong>multi-drug resistant tuberculosis </strong>and has no role in the treatment of leishmaniasis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Linezolid</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Incorrect. </strong>Linezolid is an <strong>antibiotic used against certain bacterial infections </strong>and is <strong>not </strong>effective against the <strong>protozoan parasites causing leishmaniasis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Fluconazole</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Incorrect.</strong> While<strong> fluconazole</strong> is an<strong> antifungal, </strong>it <strong>does not</strong> have efficacy against<strong> leishmaniasis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Liposomal amphotericin B</strong> is the treatment of <strong>choice for visceral leishmaniasis.</strong></span></span></span></p>",
      "correct_choice_id": 50713,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12699,
      "choices": [
        {
          "id": 50758,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifabutin</span></span></span></p>"
        },
        {
          "id": 50759,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethambutol</span></span></span></p>"
        },
        {
          "id": 50760,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifampicin</span></span></span></p>"
        },
        {
          "id": 50761,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoniazid</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-mycobacterial drug causing anterior uveitis when used along with clarithromycin:</span></span></span></p>",
      "unique_key": "Q3435344",
      "question_audio": null,
      "question_video": null,
      "map_id": 36341,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Rifabutin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Rifabutin, a rifamycin antibiotic</strong>, has been associated with the <strong>development of anterior uveitis, </strong>particularly when used <strong>concomitantly with clarithromycin. </strong>Clarithromycin is known to <strong>inhibit the metabolism of rifabutin, </strong>leading to <strong>increased plasma</strong> <strong>concentrations of rifabutin,</strong> which in turn<strong> raises the risk of uveitis. </strong>This adverse effect is particularly relevant at <strong>higher doses of</strong> <strong>rifabutin,</strong> exceeding<strong> 450 mg daily,</strong> and when<strong> combined with clarithromycin.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Ethambutol</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Incorrect. </strong>Ethambutol is an <strong>anti-mycobacterial drug </strong>known to cause <strong>visual disturbances, </strong>particularly <strong>optic</strong> <strong>neuritis,</strong> but not anterior uveitis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Rifampicin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Incorrect.</strong> Rifampicin, while a potent <strong>anti-mycobacterial medication</strong>, does not typically cause anterior uveitis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Isoniazid</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Incorrect</strong>. Isoniazid is associated with<strong> peripheral neuropathy and hepatotoxicity</strong> when considering its adverse effects, but not anterior uveitis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When treating <strong>mycobacterial infections with rifabutin, </strong>especially in <strong>conjunction with clarithromycin,</strong> it&#39;s important to be <strong>vigilant for</strong> the <strong>development of anterior uveitis.</strong> Monitoring for<strong> ocular symptoms</strong> and <strong>adjusting the dosage </strong>may be necessary to <strong>prevent this</strong> <strong>serious side effect.</strong></span></span></span></span></span></span></p>",
      "correct_choice_id": 50758,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12815,
      "choices": [
        {
          "id": 51222,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Used in combination with ritonavir as it inhibits metabolic degradation.</span></span></span></p>"
        },
        {
          "id": 51223,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atazanavir has the highest risk of causing lipodystrophy syndrome.</span></span></span></p>"
        },
        {
          "id": 51224,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indinavir treated patients should be advised to have liberal fluid intake.</span></span></span></p>"
        },
        {
          "id": 51225,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tesamorelin is used to treat lipodystrophy due to protease inhibitors.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following statements regarding the drugs used in a patient with HIV are true EXCEPT </span></span></span></p>",
      "unique_key": "Q2012056",
      "question_audio": null,
      "question_video": null,
      "map_id": 36338,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Atazanavir is not associated with the highest risk of causing lipodystrophy syndrome.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>lipodystrophy syndrome</strong> is a known side effect of<strong> protease inhibitors,</strong> the <strong>risk of developing lipodystrophy</strong> <strong>syndrome</strong> varies among <strong>different medications</strong>. <strong>Atazanavir </strong>is actually considered to be one of the <strong>protease inhibitors</strong> with a <strong>lowest risk of</strong> causing <strong>lipodystrophy syndrome</strong> compared to other <strong>protease inhibitors </strong>such as <strong>indinavir and</strong> <strong>lopinavir/ritonavir.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Ritonavir</strong> is a <strong>potent inhibitor</strong> of the <strong>cytochrome P450 3A4 (CYP3A4) enzyme</strong>, which is involved in the metabolism of many <strong>antiretroviral drugs.</strong> When<strong> used </strong>in combination with <strong>other protease inhibitors, ritonavir </strong>can <strong>increase their bioavailability </strong>by <strong>inhibiting their metabolism,</strong> thereby allowing for<strong> lower doses and reduced toxicity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Indinavir </strong>is a<strong> protease inhibitor </strong>that can cause <strong>nephrolithiasis (kidney stones)</strong> as a side effect. Patients receiving<strong> indinavir</strong> should be advised to drink at <strong>least 1.5 Liters of fluid per day</strong> to <strong>minimize this risk.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.<strong> Tesamorelin </strong>is a medication used to<strong> treat lipodystrophy syndrome in HIV-infected </strong>patients who have developed <strong>excess</strong> <strong>abdominal fat</strong> because of <strong>protease inhibitor therapy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>While protease inhibitors</strong> are <strong>effective</strong> in the treatment of<strong> HIV,</strong> they are associated with<strong> various side effects</strong>. <strong>Atazanavir,</strong> compared to other drugs in its class, carries a <strong>lower risk of causing lipodystrophy syndrome</strong>, making it a preferable<strong> choice in scenarios</strong> where <strong>minimizing the risk of metabolic complications </strong>is crucial.</span></span></span></p>",
      "correct_choice_id": 51223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}